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W
hen patients with acute cholecystitis are too ill to tolerate an operation, they may be managed by percutaneous cholecystostomy (PC) tube placement to decompress the biliary tree. Although PC has no apparent survival advantage over cholecystectomy, it does provide temporizing therapy while the patient recovers from an acute insult. [1] [2] [3] Management of the PC tube remains controversial; decisions regarding drain management vary widely across institutions. [4] [5] [6] [7] [8] In particular, the diagnostic and therapeutic yield of performing surveillance cholangiography by injecting contrast through the PC tube is unclear.
It seems likely that routine surveillance cholangiography (RSC) after PC tube placement would identify aberrant anatomy and potentially injurious stones within the biliary tree, and may therefore facilitate procedural intervention before the development of complications like recurrent cholecystitis, cholangitis, and pancreatitis. In theory, a patient with a PC tube in place has already had an acute disease of the biliary tree and may be at increased risk for additional complications. Indeed, Granlund et al. 7 performed cholangiography on 51 patients with acute cholecystitis and identified choledocholithiasis in 16%. However, the clinical significance of such findings is unclear. Collins et al. 9 observed that asymptomatic choledocholithiasis after cholecystectomy may be less consequential than once thought.
The purpose of this study was to establish optimal utilization of cholangiography after percutaneous cholecystostomy for acute cholecystitis by comparing patients who had RSC to those who underwent on-demand cholangiography (ODC) after developing signs or symptoms of biliary disease. We hypothesized that RSC after PC would identify patients with asymptomatic choledocholithiasis, but would provide no benefit in salient clinical outcomes.
METHODS
We conducted a retrospective cohort analysis of 84 consecutive patients managed with PC for acute cholecystitis at the University of Florida Health Shands Hospital or the Malcom Randall Veterans Affairs Medical Center during a 42-month period ending November 1, 2014. We included adult patients (age ≥ 18 years) meeting the TG13 Tokyo definition of acute cholecystitis (right upper quadrant mass, pain, or tenderness along with fever, leukocytosis, elevated C-reactive protein, or imaging findings characteristic of acute cholecystitis). 10 Patients transferred from outside institutions after endoscopic, radiographic, or surgical interventions on the biliary tree were excluded. Inpatient deaths were excluded so that the entire study population would be eligible for outpatient cholangiography.
Data was collected by retrospective review of the electronic medical record. Severity of acute cholecystitis was defined by TG13 Tokyo guidelines. 10 Recurrent cholecystitis was defined as a new episode of acute cholecystitis occurring after a 48-hour period in which the patient was off antibiotics and did not meet systemic inflammatory response syndrome criteria.
11 PC was performed by the transhepatic or transperitoneal route and was guided by computed tomography or ultrasound imaging. Decisions regarding cholangiography after PC and the timing of drain removal were at the discretion of the attending surgeon and interventional radiologist. All clinic and procedure notes for each patient were reviewed for a minimum of 1 year after PC.
Statistical analysis was performed using SPSS (version 23; IBM, Armonk, NY). One-way analysis of variance was used to compare normally distributed continuous variables, the Kruskal-Wallis test was used to compare non-normally distributed continuous variables, and Fisher's exact test was used to compare discrete variables. Data were reported as mean ± standard deviation (SD), n (%), or median [interquartile range (IQR)] as appropriate. Significance was set at α = 0.05.
RESULTS
Baseline comorbidities, severity of illness, improvement after PC tube placement, and hospital length of stay were similar between RSC and ODC groups ( Table 1 ). All 43 patients in RSC group were asymptomatic when they had their first cholangiogram. However, contrast did not reach the common bile duct in four patients (9%), and common bile duct filling defects were identified in six patients (14%) ( Table 2 ). Fourteen patients (33%) had repeat cholangiography, and 67 total cholangiograms were performed in this group. RSC identified six patients (14%) with cystic duct filling defects and seven patients (16%) with common bile duct filling defects. Fifteen patients in the RSC group went on to undergo 32 total endoscopic retrograde cholangiopancreatography (ERCP) procedures, and 6 of these 15 patients had endoscopic stone extraction.
Among 41 patients in the ODC group, 35 patients (85%) returned for a follow-up visit. A single cholangiogram was performed for two patients (5%) who presented with recurrent acute cholecystitis ( Table 2 ). In one case, cholangiography demonstrated that the drain had been dislodged from the gallbladder into the peritoneal space. This patient underwent laparoscopic cholecystectomy without complication. The other patient had a common bile duct defect filling defect, improved with antibiotic therapy, and left the hospital against medical advice. In the ODC group, five patients underwent seven total ERCP procedures, significantly fewer than the RSC group. The RSC group had a significantly shorter interval between PC and drain removal (Table 3 ) and shorter interval between PC and cholecystectomy (Table 4) . There were more patients who never had their drain removed in the RSC group, though this difference did not reach statistical significance. There were no significant differences in rates of recurrent cholecystitis, choledocholithiasis, cholangitis, gallstone pancreatitis, or cholecystectomy between groups. Of the 14 total deaths within 1 year of PC, the cause of death was known in 11, and none of these deaths were caused by biliary disease.
DISCUSSION
Symptom-triggered ODC was associated with earlier drain removal, earlier cholecystectomy, decreased resource utilization, and no adverse outcomes when compared to RSC. The validity of these findings was supported by uniformity between the two groups of patients when considering their initial episode of acute cholecystitis and initial hospital course. These similar baseline characteristics also suggest that the decision for RSC was arbitrarily based on the preferences of surgical and radiology teams, rather than individual patient risk stratification. As would be expected for an apparently unnecessary screening test, RSC frequently identified asymptomatic patients with incidental pathologic findings and propagated further diagnostic testing with repeat cholangiography and ERCP. However, the lack of clear benefit for this cohort supports the notion that more diagnostic information is not helpful if it does not translate to a therapeutic advantage. Incidental choledocholithiasis is relatively common. Collins et al. 9 performed a prospective study including 46 patients with asymptomatic choledocholithiasis found on intraoperative cholangiogram during laparoscopic cholecystectomy. The common bile duct was not manipulated, and the cholangiography catheter was left in place with plans for repeat cholangiogram and ERCP with stone extraction 6 weeks later. During the 6-week period, there were two isolated episodes of abdominal pain and no cases of cholangitis. 9 When repeat cholangiogram and ERCP were performed at 6 weeks, nearly three out of four of patients had persistent choledocholithiasis. 9 Several authors have reported that about 5% to 15% of patients undergoing laparoscopic cholecystectomy for uncomplicated symptomatic cholecystitis have common bile duct stones. [12] [13] [14] Surveillance cholangiography seems even more ineffectual in the setting of acalculous cholecystitis. Some clinicians may justify ongoing suspicion for gallstone-related complications after PC for acute acalculous cholecystitis based on the fact that right upper quadrant ultrasound is only 84% sensitive (95% confidence interval 76-92%) in detecting cholelithiasis, such that a substantial proportion of patients diagnosed with acalculous cholecystitis do in fact have gallstones. 15 Regardless, many authors consider PC to be a definitive therapy for patients with acalculous cholecystitis 4,16-18 because of low rates or recurrent cholecystitis. Conversely, about one in four patients with acute calculous cholecystitis may develop recurrent cholecystitis within 2 to 3 months of PCT placement. 3, 5, 7, [19] [20] [21] [22] Notably, longer duration of PC tube drainage is also a risk factor for recurrent cholecystitis. 23 Longer duration of PCT drainage has also been associated with increasing rates of readmission for gallstone-related complications. 24, 25 Although delayed drain removal among the surveillance cholangiogram group was not associated with increased incidence of recurrent cholecystitis in our study, it is feasible that prolonged PC tube drainage may represent more than an inconvenience for the patient.
The primary limitations of this study are its retrospective design and the possibility that it was underpowered to detect differences in outcomes between groups. For our purposes, retrospective analysis of a 3-year experience at two different institutions was the most practical way to obtain sample sizes large enough to make meaningful comparisons. Although including patients from two different hospitals likely increased variability in management strategies, it was our intention that the study population reflected discrepancies in practice patterns across institutions. Future studies should seek to define the optimal timing of drain removal after a period during which cholangiography is performed only if the patient develops signs or symptoms of biliary disease. Capping the PC tube before drain removal may be prudent in this setting.
CONCLUSIONS
RSC after PC for acute cholecystitis identified asymptomatic patients with incidental findings of abnormal biliary tree drainage, propagating repeat cholangiography, and ERCP. However, this approach did not decrease rates of recurrent cholecystitis, cholangitis, or gallstone pancreatitis. Patients managed with ODC had fewer ERCPs, earlier drain removal, and earlier cholecystectomy. These findings support symptom-triggered ODC after PC for acute cholecystitis to expedite care and decrease unnecessary resource utilization. 
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